First Round Capital
Listed as “Eigen Therapeutics”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Eigen Therapeutics
Company website description: Eigen is a biotechnology company developing therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies…
- Tracked VC backers
- 1
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.